Session Type
Meeting
Search Results for Checkpoint inhibitor
Abstract Number: 629
SHM Converge 2023
Case Presentation: Our patient is a 66-year-old man, a former 100-pack year smoker, with a history of hypertension, gastroesophageal reflux, emphysema, who was diagnosed in September of 2019 with stage IV squamous cell lung cancer (PD-L1 0%). He was initiated on concurrent radiation with carboplatin and nab-paclitaxel. He had a partial response to this treatment […]
Abstract Number: 636
SHM Converge 2023
Case Presentation: This case describes a 63-year-old male who was recently diagnosed with renal cell carcinoma with metastasis to the lungs confirmed with a biopsy showing diffuse PAX-8 positivity on an immunohistochemical staining panel favoring renal origin. He was started on Nivolumab/Ipilimumab however was hospitalized in the intensive care unit for septic shock due to […]
Abstract Number: 656
SHM Converge 2021
Case Presentation: An 85 y/o man with non-small cell lung cancer and osseous metastases on pembrolizumab presented with 5 months of progressive weakness, intermittent nausea with non-bloody emesis, and decreased appetite with 20 lb. unintentional weight loss. Interval cancer surveillance with PET CT obtained 1 week prior showed a decrease in disease burden suggestive of […]
Abstract Number: 676
SHM Converge 2021
Case Presentation: A 55 yo male with past medical history significant for metastatic renal cell carcinoma with no clinical evidence of residual disease on maintenance pembrolizumab, alcohol abuse, hypertension, and chronic obstructive pulmonary disease, presented after a fall with unknown loss of consciousness and head trauma. His condition progressed to acute encephalopathy with sepsis, multiorgan […]
Abstract Number: 703
SHM Converge 2021
Case Presentation: A 66-year-old female with metastatic small cell lung cancer involving brain, liver, and bones was admitted via ED with generalized weakness, mild confusion, and decreased oral intake for 3 days. She was initiated on immunotherapy with immune checkpoint inhibitors, ipilimumab (human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody) and nivolumab (a programmed death receptor-1 […]
Abstract Number: 755
SHM Converge 2024
Case Presentation: A 72-year-old male with a history of ischemic cardiomyopathy, infectious endocarditis, subarachnoid hemorrhage, and esophageal cancer presented with symptoms of fever, altered mental status, bilateral lower extremity weakness, spasms and pain. Of note, the patient was on nivolumab, undergoing targeted radiation therapy for esophageal cancer; and vancomycin and cefepime for infectious endocarditis. The […]
Abstract Number: 763
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: 44 year-old Caucasian woman presented with shortness of breath and weakness. She had a history of stage IIIC malignant melanoma (BRAF Wild Type) of right face. She underwent excision of the lesion a year prior to presentation and immunotherapy with ICI (intravenous Nivolumab 240mg every 2 weeks) was initiated. After 10 cycles of […]
Abstract Number: 786
SHM Converge 2023
Case Presentation: A 76-year-old female with a history of hypertension, BMI 48 kg/m2, hypothyroidism, and metastatic melanoma presented with a 2-week history of progressive myalgia, weakness, and dyspnea 3 weeks after the first infusion of nivolumab and relatlimab.In July 2019, she was diagnosed with stage IIB (cT4a, cN0, cM0) melanoma of the left leg (4.2 […]
Abstract Number: 813
SHM Converge 2023
Case Presentation: We present a case of a 64-year-old woman with metastatic neuroendocrine pancreatic carcinoma with abrupt left facial and oculomotor cranial nerve palsy as well spastic tetraplegia after one dose of Ipilimumab/Nivolumab. She had a history of sudden onset diplopia, fever and ground-level fall a few hours after her initial dose of immunotherapy. Initial […]
Abstract Number: 819
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 77 year old man with stage IIIC mucosal melanoma, hypothyroidism, HTN and COPD presents from an outside hospital with two months of rapidly progressive altered mental status. He was diagnosed with melanoma of the oral palate, left parotid gland and neck one year ago, and underwent two cycles of ipilimumab (ipi) and […]